The University of Kansas Hospital Cambridge North Tower A is a clinical research site located in Kansas City, Kansas, United States 66160.
Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
The University of Kansas Hospital Cambridge North Tower A has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large B-Cell, Diffuse.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Kansas · View every site in Kansas City
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of Kansas Hospital Cambridge North Tower A has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of Kansas Hospital Cambridge North Tower A has 3 clinical trials on record, with 1 currently active. Their work covers Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large B-Cell, Diffuse.
The University of Kansas Hospital Cambridge North Tower A has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.